This audit provides a comprehensive picture of UK practice. IMRT is widely used in the UK, and treatment-related toxicity is moderate. The dose fractionation was very heterogeneous. The designation of vulvar cancer as category 1 was not regularly followed for radical/adjuvant patients, and there was minimal gap compensation during treatment.
Keyphrases
- papillary thyroid
- end stage renal disease
- squamous cell
- newly diagnosed
- ejection fraction
- chronic kidney disease
- quality improvement
- healthcare
- primary care
- peritoneal dialysis
- prognostic factors
- oxidative stress
- cross sectional
- squamous cell carcinoma
- sentinel lymph node
- artificial intelligence
- high intensity
- radiation therapy
- oxide nanoparticles